AstraZeneca and Oxford University's COVID-19 vaccine trials will restart

Pharmaceutical

After being suspended on Tuesday due to a recorded side effect in a patient in the UK, AstraZeneca and Oxford University's COVID-19 vaccine trials will restart.

“AstraZeneca and Oxford University's COVID-19 vaccine trials will restart.“

The university declared that the UK regulator, the Medicines and Healthcare Products Regulatory Agency outlined that it was safe to continue and that it was predictable that some participants will fall ill in large trials.

See all the latest jobs in Pharmaceutical
Return to news